Investors Watch List: Corium International, Inc. (NASDAQ:CORI), Corning Inc. (NYSE:GLW), LKQ Corp. (NASDAQ:LKQ), Foundation Medicine, Inc. (NASDAQ:FMI), Merck & Co. Inc. (NYSE:MRK)

Corium International, Inc. (NASDAQ:CORI) belongs to Healthcare sector. Its net profit margin is -59.80% and weekly performance is 2.84%. On last trading day company shares ended up $14.50. Corium International, Inc. (NASDAQ:CORI) distance from 50-day simple moving average (SMA50) is 49.10%. Corium International Inc (NASDAQ:CORI) had its price target increased by FBR & Co. from $12.00 to $16.00 in a research report sent to investors on Friday.

Corning Inc. (NYSE:GLW) shares moved up 0.29% in last trading session and ended the day at $20.71. GLW Gross Margin is 41.80% and its return on assets is 9.30%. Corning Inc. (NYSE:GLW) quarterly performance is -13.33%. Corning Incorporated (NYSE:GLW) unveiled Corning Lotus™ NXT Glass, its third-generation glass composition for high-performance displays. The company showcased this latest innovation in booth #733 at the Society for Information Display’s (SID) Display Week in San Jose, Calif., June 2-4.

On 05 June, LKQ Corp. (NASDAQ:LKQ) shares moved up 1.67% and was closed at $29.50. LKQ EPS growth in last 5 year was 23.20%. LKQ Corp. (NASDAQ:LKQ) year to date (YTD) performance is 4.93%. LKQ Corp. (NASDAQ:LKQ) announced that members of its senior management will be presenting following investor conference: William Blair’s 35th Annual Growth Stock Conference; June 10, 2015; Four Seasons Hotel, Chicago, Illinois.

Foundation Medicine, Inc. (NASDAQ:FMI) ended the last trading day at $35.61. Company weekly volatility is calculated as 3.77% and price to cash ratio as 19.78. Foundation Medicine, Inc. (NASDAQ:FMI) showed a weekly performance of -0.45%. On May 28, it was reported that, Foundation Medicine Inc. (NASDAQ:FMI) has created a “social network” for cancer tumors, using its database of genetic information to help doctors find patients with similar cancer profiles. The biotechnology firm, which provides genomic sequencing tests for tumors, will present PatientMatch at the American Society of Clinical Oncology conference this weekend in Chicago. The company says the network is the first of its kind.

Merck & Co. Inc. (NYSE:MRK) belongs to Healthcare sector. Its net profit margin is 27.00% and weekly performance is -3.12%. On last trading day company shares ended up $58.99. Merck & Co. Inc. (NYSE:MRK) distance from 50-day simple moving average (SMA50) is 0.22%. Two former Merck & Co Inc. (NYSE:MRK) scientists accusing the drugmaker of falsifying tests of its exclusive mumps vaccine said in a court filing on Monday that Merck is refusing to respond to questions about the efficacy of the vaccine. Attorneys at Constantine Cannon, who represent the scientists, asked U.S. Magistrate Judge Lynne Sitarski of the Eastern District of Pennsylvania to compel Merck to respond to their discovery request, which asks the company to give the efficacy of the vaccine as a percentage.

There is 1 comment for this article
  1. Michael Taner at 11:25 am

    Knowing how weak this company is, do not advise as good choice. I would not consume this companies products. Technology is basically medicine topical. Very low tech.

Leave a Reply

Your email address will not be published. Required fields are marked *